Tezosentan

From Wikipedia, the free encyclopedia
This is the current revision of this page, as edited by imported>JWBE at 18:13, 14 June 2025 (removed Category:Pyridines; added Category:Disubstituted pyridines using HotCat). The present address (URL) is a permanent link to this version.
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Short description Template:Drugbox

Tezosentan is a non-selective ETA and ETB receptor antagonist.[1] It acts as a vasodilator and was designed by Actelion as a therapy for patients with acute heart failure. However, studies showed that tezosentan did not improve dyspnea or reduce the risk of fatal or nonfatal cardiovascular events.[2]

References

<templatestyles src="Reflist/styles.css" />

  1. ↑ Script error: No such module "Citation/CS1".
  2. ↑ Script error: No such module "citation/CS1".

Script error: No such module "Check for unknown parameters".

Script error: No such module "Navbox".


Template:Cardiovascular-drug-stub